These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 2090716

  • 1. Regulation of hepatic cholesterol metabolism in humans: stimulatory effects of cholestyramine on HMG-CoA reductase activity and low density lipoprotein receptor expression in gallstone patients.
    Reihnér E, Angelin B, Rudling M, Ewerth S, Björkhem I, Einarsson K.
    J Lipid Res; 1990 Dec; 31(12):2219-26. PubMed ID: 2090716
    [Abstract] [Full Text] [Related]

  • 2. Differing effects of cholesterol and taurocholate on steady state hepatic HMG-CoA reductase and cholesterol 7 alpha-hydroxylase activities and mRNA levels in the rat.
    Shefer S, Nguyen LB, Salen G, Ness GC, Chowdhary IR, Lerner S, Batta AK, Tint GS.
    J Lipid Res; 1992 Aug; 33(8):1193-200. PubMed ID: 1431598
    [Abstract] [Full Text] [Related]

  • 3. Studies on the regulation of cholesterol 7 alpha-hydroxylase and HMG-CoA reductase in rat liver: effects of lymphatic drainage and ligation of the lymph duct.
    Akerlund JE, Björkhem I.
    J Lipid Res; 1990 Dec; 31(12):2159-66. PubMed ID: 2090709
    [Abstract] [Full Text] [Related]

  • 4. Regulation of hepatic cholesterol metabolism in man.
    Angelin B.
    Ann Med; 1991 Apr; 23(2):177-80. PubMed ID: 1906288
    [Abstract] [Full Text] [Related]

  • 5. Hepatic cholesterol metabolism in estrogen-treated men.
    Angelin B, Olivecrona H, Reihnér E, Rudling M, Ståhlberg D, Eriksson M, Ewerth S, Henriksson P, Einarsson K.
    Gastroenterology; 1992 Nov; 103(5):1657-63. PubMed ID: 1426886
    [Abstract] [Full Text] [Related]

  • 6. Influence of pravastatin, a specific inhibitor of HMG-CoA reductase, on hepatic metabolism of cholesterol.
    Reihnér E, Rudling M, Ståhlberg D, Berglund L, Ewerth S, Björkhem I, Einarsson K, Angelin B.
    N Engl J Med; 1990 Jul 26; 323(4):224-8. PubMed ID: 2114543
    [Abstract] [Full Text] [Related]

  • 7. Ursodeoxycholic acid treatment in cholesterol gallstone disease: effects on hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase activity, biliary lipid composition, and plasma lipid levels.
    Angelin B, Ewerth S, Einarsson K.
    J Lipid Res; 1983 Apr 26; 24(4):461-8. PubMed ID: 6854153
    [Abstract] [Full Text] [Related]

  • 8. Hepatic low density lipoprotein receptors, HMG-CoA reductase, and plasma lipids and apolipoproteins in high- and low-responding rhesus monkeys: effect of cholestyramine treatment.
    Dory L, Bhattacharyya A, Strong J, Chappuis C.
    J Lipid Res; 1990 Feb 26; 31(2):279-87. PubMed ID: 2324647
    [Abstract] [Full Text] [Related]

  • 9. Hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase activity and biliary lipid composition in man: relation to cholesterol gallstone disease and effects of cholic acid and chenodeoxycholic acid treatment.
    Ahlberg J, Angelin B, Einarsson K.
    J Lipid Res; 1981 Mar 26; 22(3):410-22. PubMed ID: 7240966
    [Abstract] [Full Text] [Related]

  • 10. Effect of chenodeoxycholic acid and phenobarbital on the rate-limiting enzymes of hepatic cholesterol and bile acid synthesis in patients with gallstones.
    Coyne MJ, Bonorris GG, Goldstein LI, Schoenfield LJ.
    J Lab Clin Med; 1976 Feb 26; 87(2):281-91. PubMed ID: 1245792
    [Abstract] [Full Text] [Related]

  • 11. Hepatic cholesterol and bile acid metabolism in subjects with gallstones: comparative effects of short erm feeding of chenodeoxycholic and ursodeoxycholic acid.
    Carulli N, Ponz De Leon M, Zironi F, Pinetti A, Smerieri A, Iori R, Loria P.
    J Lipid Res; 1980 Jan 26; 21(1):35-43. PubMed ID: 7354253
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The level of 7-dehydrocholesterol in plasma reflects the activity of 3-hydroxy-3-methylglutaryl coenzyme A reductase in the human liver.
    Axelson M, Angelin B, Hillebrant CG, Reihnér E, Einarsson C.
    Biochim Biophys Acta; 1998 Nov 02; 1394(2-3):153-7. PubMed ID: 9795194
    [Abstract] [Full Text] [Related]

  • 15. Bile acid sequestrants: mechanisms of action on bile acid and cholesterol metabolism.
    Einarsson K, Ericsson S, Ewerth S, Reihnér E, Rudling M, Ståhlberg D, Angelin B.
    Eur J Clin Pharmacol; 1991 Nov 02; 40 Suppl 1():S53-8. PubMed ID: 2044645
    [Abstract] [Full Text] [Related]

  • 16. SK&F 97426-A a more potent bile acid sequestrant and hypocholesterolaemic agent than cholestyramine in the hamster.
    Benson GM, Alston DR, Bond BC, Gee AN, Glen A, Haynes C, Hickey DM, Iqbal S, Jackson B, Jaxa-Chamiec AA.
    Atherosclerosis; 1993 Jun 02; 101(1):51-60. PubMed ID: 8216502
    [Abstract] [Full Text] [Related]

  • 17. Deoxycholic acid treatment in patients with cholesterol gallstones: failure to detect a suppression of cholesterol 7alpha-hydroxylase activity.
    Hillebrant C, Nyberg B, Angelin B, Axelson M, Björkhem I, Rudling M, Einarsson C.
    J Intern Med; 1999 Oct 02; 246(4):399-407. PubMed ID: 10583711
    [Abstract] [Full Text] [Related]

  • 18. Some effects of chitosan on liver function in the rat.
    LeHoux JG, Grondin F.
    Endocrinology; 1993 Mar 02; 132(3):1078-84. PubMed ID: 7679967
    [Abstract] [Full Text] [Related]

  • 19. Influence of maternal cholestyramine treatment on cholesterol and bile acid metabolism in adult offspring.
    Innis SM.
    J Nutr; 1983 Dec 02; 113(12):2464-70. PubMed ID: 6655510
    [Abstract] [Full Text] [Related]

  • 20. Interruption of the enterohepatic circulation of bile acids stimulates the esterification rate of cholesterol in human liver.
    Ståhlberg D, Reihnér E, Angelin B, Einarsson K.
    J Lipid Res; 1991 Sep 02; 32(9):1409-15. PubMed ID: 1753211
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.